Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa‐foeto‐protein (AFP), neuron‐specific enolase (NSE) and CA19.9 from the NORIP study-Reference-Cited by-同舟云学术

Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa‐foeto‐protein (AFP), neuron‐specific enolase (NSE) and CA19.9 from the NORIP study

Published:2008-01-01 Issue:8 Volume:68 Page:703-713
ISSN:0036-5513
Container-title:Scandinavian Journal of Clinical and Laboratory Investigation
language:en
Short-container-title:Scandinavian Journal of Clinical and Laboratory Investigation

Author:

Bjerner Johan¹,Høgetveit Anita¹,Wold Akselberg Katrine¹,Vangsnes Kirsti¹,Paus Elisabeth¹,Bjøro Trine¹,Børmer Ole Petter¹,Nustad Kjell¹

Affiliation:

1. Central Laboratory, Norwegian Radium Hospital, Montebello, Oslo, Norway

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365510802126836

Reference40 articles.

1. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties

2. Nordic Reference Interval Project Bio‐bank and Database (NOBIDA): a source for future estimation and retrospective evaluation of reference intervals

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A preliminary study on the reference intervals of serum tumor marker in apparently healthy elderly population in southwestern China using real-world data;BMC Cancer;2024-05-29

2. Establishment of CA19-9 reference intervals in an apparently healthy adult population in Singapore;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2023-12-26

3. Establishment and validation of reference intervals for tumor markers (AFP, CEA, CA19‐9, CA15‐3, CA125, PSA, HE4, Cyfra 21‐1, and ProGRP) in primary care centers in Korea: A cross‐sectional retrospective study;Health Science Reports;2023-02

4. The Pre-analytical Phase;Clinical and Laboratory Medicine Textbook;2023

5. Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction;BMC Cancer;2022-06-22